# Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

> **NCT03631771** · PHASE4 · WITHDRAWN · sponsor: **GE Healthcare**

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Iohexol
- **DRUG:** Iodixanol
- **DRUG:** Iopromide
- **DRUG:** Ioversol

## Key facts

- **NCT ID:** NCT03631771
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03
- **Primary completion:** 2024-08
- **Final completion:** 2025-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** It was determined that a study is no longer required because the clinical question posed by the study has been answered through published literature
- **Last updated:** 2022-04-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03631771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03631771, "Pediatric Risk of Hypothyroidism With Iodinated Contrast Media". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT03631771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*